New Analysis Showed That High Dose Lipitor Can Reduce The Risk Of Cardiovascular Events In Bypass...

medicalnewstoday.com     May 23, 2008            

Pfizer Inc announced that Lipitor® (atorvastatin calcium) 80 mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27 percent in patients with heart disease who had previous coronary bypass surgery compared with patients taking the 10 mg dose of... [read full story]                    


*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies